Cargando…
An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity
Monitoring of the level of the virus-neutralizing activity of serum immunoglobulins ensures that one can reliably assess the effectiveness of any protection against the SARS-CoV-2 infection. For SARS-CoV-2, the RBD-ACE2 neutralizing activity of sera is almost equivalent to the virus-neutralizing act...
Autores principales: | Kostin, N. N., Bobik, T. V., Skryabin, G. A., Simonova, M. A., Knorre, V. D., Abrikosova, V. A., Mokrushina, Y. A., Smirnov, I. V., Aleshenko, N. L., Kruglova, N. A., Mazurov, D. V., Nikitin, A. E., Gabibov, A. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611858/ https://www.ncbi.nlm.nih.gov/pubmed/36348715 http://dx.doi.org/10.32607/actanaturae.11776 |
Ejemplares similares
-
COVID-19 in Russia: Clinical and Immunological Features of the First-Wave Patients
por: Bobik, T. V., et al.
Publicado: (2021) -
Epitope-Specific Response of Human Milk Immunoglobulins in COVID-19 Recovered Women
por: Bobik, Tatyana V., et al.
Publicado: (2021) -
B Cell Profiling in Patients with Pemphigus Vulgaris
por: Abrikosova, V. A., et al.
Publicado: (2023) -
High Heterogeneity of Virus-Neutralizing and RBD-Binding Activities of COVID-19 Convalescent Sera
por: Astakhova, E. A., et al.
Publicado: (2022) -
Recombinant Human Butyrylcholinesterase As a New-Age Bioscavenger Drug: Development of the Expression System
por: Ilyushin, D.G., et al.
Publicado: (2013)